Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug validation factors affecting

As the stability data can be affected by many factors like formulation, manufacturing, storage conditions, in-process and GMP controls, analytical methods, and process validation, the biggest challenge is to figure out the source of the variability in the stability results. At least three batches of the drug substance or product are required to establish the acceptance criteria for future production batches as a measurement... [Pg.344]

Factors analogous to those affecting gut absorption also can affect drug distribution and excretion. Any transporters or metabolizing enzymes can be taxed to capacity—which clearly would make the kinetic process nonlinear (see Linear versus Nonlinear Pharmacokinetics ). In order to have linear pharmacokinetics, all components (distribution, metabolism, filtration, active secretion, and active reabsorption) must be reasonably approximated by first-order kinetics for the valid design of controlled release delivery systems. [Pg.15]

A summary report, including protocols and results, should be provided for the validation studies of each critical process or factor that affects the drug substance specifications for ... [Pg.173]

Analytical method validation has developed within the pharmaceutical industry over the years in order to produce an assurance of the capabilities of an analytical method. A recent text on validation of analytical techniques has been published by the international Conference on Harmonisation (ICH) [19]. This discusses the four most common analytical procedures (1) identification test, (2) quantitative measurements for content of impurities, (3) limit test for the control of impurities and (4) quantitative measurement of the active moiety in samples of drug substance or drug product or other selected components of the drug product. As in any analytical method, the characteristics of the assay are determined and used to provide quantitative data which demonstrate the analytical validation. The reported validation data for CE are identical to those produced by an LC or GC method [11] and are derived from the same parameters, i.e. peak time and response. Those validation parameters featured by the ICH (Table 1) are derived from the peak data generated by the method. Table 1 also indicates those aspects of a CE method (instrumentation and chemistry), peculiar to the technique, which can affect the peak data and highlights factors which can assist the user in demonstrating the validation parameters. [Pg.18]


See other pages where Drug validation factors affecting is mentioned: [Pg.327]    [Pg.15]    [Pg.485]    [Pg.293]    [Pg.254]    [Pg.178]    [Pg.1145]    [Pg.236]    [Pg.230]    [Pg.74]    [Pg.23]    [Pg.126]    [Pg.649]    [Pg.347]    [Pg.349]    [Pg.151]    [Pg.73]    [Pg.401]    [Pg.27]    [Pg.223]    [Pg.205]    [Pg.84]    [Pg.829]    [Pg.106]    [Pg.222]    [Pg.1480]    [Pg.415]    [Pg.180]    [Pg.110]    [Pg.156]    [Pg.16]    [Pg.443]    [Pg.142]    [Pg.180]    [Pg.170]    [Pg.372]    [Pg.349]    [Pg.35]   
See also in sourсe #XX -- [ Pg.92 ]




SEARCH



Drug validation

© 2024 chempedia.info